The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anticoagulant Market Research Report 2024
Synopsis
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
The global Anticoagulant market was valued at US$ 2458.4 million in 2023 and is anticipated to reach US$ 3774.1 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.
North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
This report aims to provide a comprehensive presentation of the global market for Anticoagulant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulant.
Report Scope
The Anticoagulant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticoagulant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anticoagulant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Pfizer
Johnson & Johnson
Sanofi
AstraZeneca
Eli Lilly
Keryx Biopharmaceuticals
Segment by Type
Oral
Injectable
Segment by Application
DVT
PE
AF
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anticoagulant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anticoagulant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
The global Anticoagulant market was valued at US$ 2458.4 million in 2023 and is anticipated to reach US$ 3774.1 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.
North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
This report aims to provide a comprehensive presentation of the global market for Anticoagulant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulant.
Report Scope
The Anticoagulant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticoagulant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anticoagulant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Pfizer
Johnson & Johnson
Sanofi
AstraZeneca
Eli Lilly
Keryx Biopharmaceuticals
Segment by Type
Oral
Injectable
Segment by Application
DVT
PE
AF
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anticoagulant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anticoagulant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anticoagulant Market Overview
1.1 Product Overview and Scope of Anticoagulant
1.2 Anticoagulant Segment by Type
1.2.1 Global Anticoagulant Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Injectable
1.3 Anticoagulant Segment by Application
1.3.1 Global Anticoagulant Market Value by Application: (2024-2030)
1.3.2 DVT
1.3.3 PE
1.3.4 AF
1.4 Global Anticoagulant Market Size Estimates and Forecasts
1.4.1 Global Anticoagulant Revenue 2019-2030
1.4.2 Global Anticoagulant Sales 2019-2030
1.4.3 Global Anticoagulant Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anticoagulant Market Competition by Manufacturers
2.1 Global Anticoagulant Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anticoagulant Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anticoagulant Average Price by Manufacturers (2019-2024)
2.4 Global Anticoagulant Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anticoagulant, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anticoagulant, Product Type & Application
2.7 Anticoagulant Market Competitive Situation and Trends
2.7.1 Anticoagulant Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anticoagulant Players Market Share by Revenue
2.7.3 Global Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anticoagulant Retrospective Market Scenario by Region
3.1 Global Anticoagulant Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anticoagulant Global Anticoagulant Sales by Region: 2019-2030
3.2.1 Global Anticoagulant Sales by Region: 2019-2024
3.2.2 Global Anticoagulant Sales by Region: 2025-2030
3.3 Global Anticoagulant Global Anticoagulant Revenue by Region: 2019-2030
3.3.1 Global Anticoagulant Revenue by Region: 2019-2024
3.3.2 Global Anticoagulant Revenue by Region: 2025-2030
3.4 North America Anticoagulant Market Facts & Figures by Country
3.4.1 North America Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anticoagulant Sales by Country (2019-2030)
3.4.3 North America Anticoagulant Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anticoagulant Market Facts & Figures by Country
3.5.1 Europe Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anticoagulant Sales by Country (2019-2030)
3.5.3 Europe Anticoagulant Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anticoagulant Market Facts & Figures by Country
3.6.1 Asia Pacific Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anticoagulant Sales by Country (2019-2030)
3.6.3 Asia Pacific Anticoagulant Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anticoagulant Market Facts & Figures by Country
3.7.1 Latin America Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anticoagulant Sales by Country (2019-2030)
3.7.3 Latin America Anticoagulant Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anticoagulant Market Facts & Figures by Country
3.8.1 Middle East and Africa Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anticoagulant Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anticoagulant Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anticoagulant Sales by Type (2019-2030)
4.1.1 Global Anticoagulant Sales by Type (2019-2024)
4.1.2 Global Anticoagulant Sales by Type (2025-2030)
4.1.3 Global Anticoagulant Sales Market Share by Type (2019-2030)
4.2 Global Anticoagulant Revenue by Type (2019-2030)
4.2.1 Global Anticoagulant Revenue by Type (2019-2024)
4.2.2 Global Anticoagulant Revenue by Type (2025-2030)
4.2.3 Global Anticoagulant Revenue Market Share by Type (2019-2030)
4.3 Global Anticoagulant Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anticoagulant Sales by Application (2019-2030)
5.1.1 Global Anticoagulant Sales by Application (2019-2024)
5.1.2 Global Anticoagulant Sales by Application (2025-2030)
5.1.3 Global Anticoagulant Sales Market Share by Application (2019-2030)
5.2 Global Anticoagulant Revenue by Application (2019-2030)
5.2.1 Global Anticoagulant Revenue by Application (2019-2024)
5.2.2 Global Anticoagulant Revenue by Application (2025-2030)
5.2.3 Global Anticoagulant Revenue Market Share by Application (2019-2030)
5.3 Global Anticoagulant Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Anticoagulant Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Anticoagulant Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Bristol-Myers Squibb
6.3.1 Bristol-Myers Squibb Corporation Information
6.3.2 Bristol-Myers Squibb Description and Business Overview
6.3.3 Bristol-Myers Squibb Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bristol-Myers Squibb Anticoagulant Product Portfolio
6.3.5 Bristol-Myers Squibb Recent Developments/Updates
6.4 Daiichi Sankyo
6.4.1 Daiichi Sankyo Corporation Information
6.4.2 Daiichi Sankyo Description and Business Overview
6.4.3 Daiichi Sankyo Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Daiichi Sankyo Anticoagulant Product Portfolio
6.4.5 Daiichi Sankyo Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Anticoagulant Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Johnson & Johnson Anticoagulant Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Anticoagulant Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AstraZeneca Anticoagulant Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Eli Lilly Anticoagulant Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Keryx Biopharmaceuticals
6.10.1 Keryx Biopharmaceuticals Corporation Information
6.10.2 Keryx Biopharmaceuticals Description and Business Overview
6.10.3 Keryx Biopharmaceuticals Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Keryx Biopharmaceuticals Anticoagulant Product Portfolio
6.10.5 Keryx Biopharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anticoagulant Industry Chain Analysis
7.2 Anticoagulant Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anticoagulant Production Mode & Process
7.4 Anticoagulant Sales and Marketing
7.4.1 Anticoagulant Sales Channels
7.4.2 Anticoagulant Distributors
7.5 Anticoagulant Customers
8 Anticoagulant Market Dynamics
8.1 Anticoagulant Industry Trends
8.2 Anticoagulant Market Drivers
8.3 Anticoagulant Market Challenges
8.4 Anticoagulant Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
